Selank Peptide – 10mg

Selank (10mg) — Research Compound

Selank is a synthetic heptapeptide analogue of the naturally occurring tetrapeptide tuftsin, modified to include a glyproline sequence for increased stability. It is primarily studied for its anxiolytic (anti-anxiety) properties and its ability to modulate the metabolism of serotonin and other neurotransmitters in the brain. Unlike traditional sedatives, Selank is investigated for its potential to provide regulatory effects on the central nervous system without inducing drowsiness or cognitive impairment.

Findings from early-stage clinical trials have reported:

• Reductions in anxiety-related behaviors and stress markers observed in experimental subjects
  
• Increased expression of Brain-Derived Neurotrophic Factor (BDNF) reported in hippocampal research
  
• Modulation of the GABAergic system and alterations in serotonin metabolism noted in-vivo
  
• Enhanced immune system signaling, specifically relating to cytokine balance, observed in research cohorts
  

Researchers study Selank to investigate the intersection of the nervous and immune systems. Its ability to act as a regulatory agent makes it a valuable tool for exploring neuroprotection, cognitive enhancement, and the biological response to chronic stress. It is a focal point for research into the management of neurochemical imbalances and the preservation of cognitive function during environmental stressors.

Available Formats:
This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

References

Mechanisms of action of Selank and related regulatory peptides

This publication reviews the biological activity of Selank and its relevance in neurobiological and behavioural research models. Source Link: Available here

Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo

This study reports increased hippocampal BDNF expression following Selank administration, relevant to research on cognitive and neurotrophic pathways. Source Link: Available here

The optimizing action of the synthetic peptide Selank on learning and memory processes

This study investigates Selank’s effects on learning and memory consolidation in experimental models. Source Link: Available here

Effects of the new peptide anxiolytic drug Selank on exploratory activity and emotional state in experimental models

This study assesses behavioural and emotional-state changes associated with Selank administration in preclinical research. Source Link: Available here

Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia

This clinical study evaluates Selank’s anxiolytic and antiasthenic effects in patients with generalized anxiety disorder. Source Link: Available here

The molecular aspects of heptapeptide Selank biological activity

This review consolidates the proposed molecular mechanisms underlying Selank’s anxiolytic and nootropic activity. Source Link: Available here

Selank, peptide analogue of tuftsin, protects against ethanol-induced memory impairment by regulating BDNF content in the hippocampus and prefrontal cortex in rats

This study examines Selank’s protective effect on memory function via hippocampal and prefrontal BDNF regulation. Source Link: Available here